Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAT2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | MS4A7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | COX19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | SFXN3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | PLEKHG3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | SPNS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | CUL2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | DAZAP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | THAP2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | LGALS12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |